Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Cash from Financing Activities (2022 - 2025)

Historic Cash from Financing Activities for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to -$293.0 million.

  • GE HealthCare Technologies' Cash from Financing Activities rose 7705.56% to -$293.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $617.0 million, marking a year-over-year increase of 20767.89%. This contributed to the annual value of $617.0 million for FY2025, which is 20767.89% up from last year.
  • As of Q4 2025, GE HealthCare Technologies' Cash from Financing Activities stood at -$293.0 million, which was up 7705.56% from -$165.0 million recorded in Q3 2025.
  • In the past 5 years, GE HealthCare Technologies' Cash from Financing Activities ranged from a high of $1.4 billion in Q2 2025 and a low of -$1.3 billion during Q4 2024
  • Over the past 4 years, GE HealthCare Technologies' median Cash from Financing Activities value was -$159.0 million (recorded in 2024), while the average stood at -$78.5 million.
  • In the last 5 years, GE HealthCare Technologies' Cash from Financing Activities crashed by 233243.24% in 2023 and then surged by 390833.33% in 2024.
  • GE HealthCare Technologies' Cash from Financing Activities (Quarter) stood at -$37.0 million in 2022, then tumbled by 2332.43% to -$900.0 million in 2023, then crashed by 41.89% to -$1.3 billion in 2024, then soared by 77.06% to -$293.0 million in 2025.
  • Its last three reported values are -$293.0 million in Q4 2025, -$165.0 million for Q3 2025, and $1.4 billion during Q2 2025.